US Map / Oklahoma
State OK

Clinical Trials in Oklahoma

Recruiting clinical trials with at least one study location in Oklahoma. Data updated daily from ClinicalTrials.gov.

Total Trials
126
Recruiting Now
126
← Back to US Map
Top Conditions in Oklahoma
Malignant Solid Neoplasm (6)Ovarian Cancer (5)Endometrial Cancer (5)Breast Cancer (4)Colorectal Cancer (4)Melanoma (3)Major Depressive Disorder (3)Anatomic Stage IV Breast Cancer AJCC v8 (3)Clinical Stage III Gastric Cancer AJCC v8 (3)Clinical Stage IV Gastric Cancer AJCC v8 (3)Lung Non-Small Cell Carcinoma (2)Sarcoma (2)
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07215312 Phase 2
Recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated Wit...
Condition
Diabetes Mellitus, Type 2
Enrollment
100 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
View Trial →
NCT06897475 Phase 2
Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes ...
Condition
Type 2 Diabetes
Enrollment
240 pts
Location
United States, Canada, Germany
Sponsor
Eli Lilly and Company
View Trial →
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
View Trial →
NCT04077762 N/A
Recruiting
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complica...
Condition
Patient Satisfaction
Enrollment
3,266 pts
Location
United States
Sponsor
Minneapolis Heart Institute Fo
View Trial →
NCT05076942 Phase 2
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Condition
Vulvar Cancer
Enrollment
157 pts
Location
United States, Netherlands
Sponsor
University Medical Center Gron
View Trial →
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Condition
HER2 Mutation-Related Tumors
Enrollment
243 pts
Location
United States, France, Ireland
Sponsor
Iambic Therapeutics, Inc
View Trial →
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
View Trial →
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07413692 N/A
Recruiting
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and ...
Condition
Depressive Symptoms
Enrollment
60 pts
Location
United States
Sponsor
BTL Industries Ltd.
View Trial →
NCT04042844 Phase 2
Recruiting
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Condition
Lumbar Disc Disease
Enrollment
99 pts
Location
United States
Sponsor
BioRestorative Therapies
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
View Trial →
NCT05853601 Phase 1, Phase 2
Recruiting
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
Condition
Acute Kidney Injury
Enrollment
30 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT05230732 N/A
Recruiting
Neuromodulation of Inflammation and Endothelial Function
Condition
Systolic Heart Failure
Enrollment
158 pts
Location
United States
Sponsor
University of Oklahoma
View Trial →
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07353931 Phase 3
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthri...
Condition
Osteoarthritis
Enrollment
900 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT04426461 N/A
Recruiting
Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Ou...
Condition
Anxiety
Enrollment
220 pts
Location
United States
Sponsor
Laureate Institute for Brain R
View Trial →
NCT05975983 Phase 2
Recruiting
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulm...
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
40 pts
Location
United States
Sponsor
InSilico Medicine Hong Kong Li
View Trial →
Page 4 of 6 — 126 trials total
← Prev Next →